AI assistant
Sending…
Enveric Biosciences, Inc. — Director's Dealing 2017
Apr 14, 2017
35460_dirs_2017-04-14_7387fc59-96cc-4aa1-9c53-e838a152dcb4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMERI Holdings, Inc. (AMRH)
CIK: 0000890821
Period of Report: 2017-04-11
Reporting Person: Pearse Robert G. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-04-11 | Restricted Stock Unit | $ | A | 9063 | Acquired | Common Stock (9063) | Direct | |
| 2017-04-11 | Restricted Stock Unit | $ | A | 9063 | Acquired | Common Stock (9063) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 16809 | Direct |
Footnotes
F1: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock.
F2: These Restricted Stock Units are scheduled to vest on May 1, 2017.
F3: These Restricted Stock Units are scheduled to vest on January 1, 2018.
More from Enveric Biosciences, Inc.
Share Issue/Capital Change
2026
May 29
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 4
Report Publication Announcement
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Regulatory Filings
2026
Apr 30
Capital/Financing Update
2026
Apr 29
Regulatory Filings
2026
Apr 23